Aspen Aerogels (NYSE:ASPN) PT Raised to $29.00 at Piper Sandler

Aspen Aerogels (NYSE:ASPN) had its price target lifted by investment analysts at Piper Sandler from $20.00 to $29.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the construction company’s stock. Piper Sandler’s price objective would indicate a potential upside of 15.49% from the stock’s current price.

Several other research analysts also recently issued reports on ASPN. Roth Mkm reissued a “buy” rating and set a $22.00 price objective on shares of Aspen Aerogels in a research report on Tuesday, April 30th. HC Wainwright boosted their price target on Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Friday. Finally, TheStreet raised Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $25.17.

Aspen Aerogels Stock Up 5.3 %

Aspen Aerogels stock opened at $25.11 on Friday. The company has a market capitalization of $1.93 billion, a P/E ratio of -57.07 and a beta of 1.97. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.91 and a current ratio of 3.41. Aspen Aerogels has a fifty-two week low of $5.32 and a fifty-two week high of $25.65. The stock has a 50-day simple moving average of $16.72 and a 200-day simple moving average of $13.73.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. The company had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. Aspen Aerogels had a negative return on equity of 6.54% and a negative net margin of 10.73%. During the same quarter in the previous year, the business earned ($0.20) earnings per share. Equities research analysts expect that Aspen Aerogels will post 0.03 earnings per share for the current year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently modified their holdings of the business. GSA Capital Partners LLP acquired a new position in Aspen Aerogels during the first quarter worth $1,181,000. BNP Paribas Financial Markets grew its stake in shares of Aspen Aerogels by 85.2% during the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after purchasing an additional 11,823 shares during the period. Bridgewater Advisors Inc. purchased a new position in shares of Aspen Aerogels in the 1st quarter valued at about $750,000. Assenagon Asset Management S.A. acquired a new stake in shares of Aspen Aerogels in the first quarter valued at about $636,000. Finally, Harbour Capital Advisors LLC acquired a new stake in shares of Aspen Aerogels in the first quarter valued at about $404,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.